Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Hikma Pharmaceuticals Price to Book Value: 2.473 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.473 |
| May 03, 2024 | 2.473 |
| May 02, 2024 | 2.254 |
| May 01, 2024 | 2.254 |
| April 30, 2024 | 2.254 |
| April 29, 2024 | 2.254 |
| April 26, 2024 | 2.254 |
| April 25, 2024 | 2.254 |
| April 24, 2024 | 2.254 |
| April 23, 2024 | 2.254 |
| April 22, 2024 | 2.254 |
| April 19, 2024 | 2.254 |
| April 18, 2024 | 2.254 |
| April 17, 2024 | 2.254 |
| April 16, 2024 | 2.448 |
| April 15, 2024 | 2.448 |
| April 12, 2024 | 2.448 |
| April 11, 2024 | 2.448 |
| April 10, 2024 | 2.448 |
| April 09, 2024 | 2.448 |
| April 08, 2024 | 2.448 |
| April 05, 2024 | 2.448 |
| April 04, 2024 | 2.448 |
| April 03, 2024 | 2.448 |
| April 02, 2024 | 2.448 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.448 |
| March 28, 2024 | 2.359 |
| March 27, 2024 | 2.359 |
| March 26, 2024 | 2.359 |
| March 25, 2024 | 2.359 |
| March 22, 2024 | 2.359 |
| March 21, 2024 | 2.359 |
| March 20, 2024 | 2.359 |
| March 19, 2024 | 2.359 |
| March 18, 2024 | 2.359 |
| March 15, 2024 | 2.359 |
| March 14, 2024 | 2.359 |
| March 13, 2024 | 2.359 |
| March 12, 2024 | 2.359 |
| March 11, 2024 | 2.359 |
| March 08, 2024 | 2.359 |
| March 07, 2024 | 2.359 |
| March 06, 2024 | 2.433 |
| March 05, 2024 | 2.455 |
| March 04, 2024 | 2.455 |
| March 01, 2024 | 2.455 |
| February 29, 2024 | 2.455 |
| February 28, 2024 | 2.666 |
| February 27, 2024 | 2.666 |
| February 26, 2024 | 2.666 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.392
Minimum
Sep 23 2022
4.309
Maximum
Nov 25 2020
2.858
Average
2.793
Median
Feb 18 2020
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 6.871 |
| Biodexa Pharmaceuticals Plc | 0.7432 |
| Verona Pharma PLC | 4.798 |
| NuCana PLC | 0.4393 |
| Autolus Therapeutics PLC | 9.566 |
Price to Book Value Related Metrics
| PE Ratio | 28.82 |
| PS Ratio | 1.895 |
| Price to Free Cash Flow | 10.22 |
| Price | 24.50 |
| Earnings Yield | 3.47% |
| Market Cap | 5.436B |
| Operating PE Ratio | 9.020 |
| Normalized PE Ratio | 15.08 |